APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit

Compare research editions
View pricing & licenses

Selected research

Industry Research

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Research Report 2026

24 December 2025125 pages

Choose your research edition.

Industry ResearchHuman EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit include Yuanma Gene, Shihe Medical, Xiamen Feishuo Biotechnology, Burning Rock, Qiuzhen Medical, Novogene, Jinqirui Biotechnology, BGI and Hangzhou Lianchuan Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Company

Yuanma Gene

Shihe Medical

Xiamen Feishuo Biotechnology

Burning Rock

Qiuzhen Medical

Novogene

Jinqirui Biotechnology

BGI

Hangzhou Lianchuan Gene

TRUPCR

HLB PanaGene

AmoyDx

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Type

Sequencing Method

Fluorescence PCR Method

Other

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Application

Clinical

Scientific Research

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Manufacturers (2021-2026) Table 8. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue of Manufacturers (2021-2026) Table 9. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, Product Type & Application Table 14. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Yuanma Gene Company Information Table 19. Yuanma Gene Business Overview Table 20. Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 22. Yuanma Gene Recent Developments Table 23. Shihe Medical Company Information Table 24. Shihe Medical Business Overview Table 25. Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 27. Shihe Medical Recent Developments Table 28. Xiamen Feishuo Biotechnology Company Information Table 29. Xiamen Feishuo Biotechnology Business Overview Table 30. Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 32. Xiamen Feishuo Biotechnology Recent Developments Table 33. Burning Rock Company Information Table 34. Burning Rock Business Overview Table 35. Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 37. Burning Rock Recent Developments Table 38. Qiuzhen Medical Company Information Table 39. Qiuzhen Medical Business Overview Table 40. Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 42. Qiuzhen Medical Recent Developments Table 43. Novogene Company Information Table 44. Novogene Business Overview Table 45. Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 47. Novogene Recent Developments Table 48. Jinqirui Biotechnology Company Information Table 49. Jinqirui Biotechnology Business Overview Table 50. Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 52. Jinqirui Biotechnology Recent Developments Table 53. BGI Company Information Table 54. BGI Business Overview Table 55. BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 57. BGI Recent Developments Table 58. Hangzhou Lianchuan Gene Company Information Table 59. Hangzhou Lianchuan Gene Business Overview Table 60. Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 62. Hangzhou Lianchuan Gene Recent Developments Table 63. TRUPCR Company Information Table 64. TRUPCR Business Overview Table 65. TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 67. TRUPCR Recent Developments Table 68. HLB PanaGene Company Information Table 69. HLB PanaGene Business Overview Table 70. HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 72. HLB PanaGene Recent Developments Table 73. AmoyDx Company Information Table 74. AmoyDx Business Overview Table 75. AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio Table 77. AmoyDx Recent Developments Table 78. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2021-2026) & (K Units) Table 80. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Region (2021-2026) Table 81. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2027-2032) & (K Units) Table 82. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Region (2027-2032) Table 83. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Region (2021-2026) Table 85. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Region (2027-2032) Table 87. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026) & (K Units) Table 89. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032) & (K Units) Table 90. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026) & (K Units) Table 94. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032) & (K Units) Table 95. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026) & (K Units) Table 99. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032) & (K Units) Table 100. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026) & (K Units) Table 104. South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032) & (K Units) Table 105. South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2026) & (K Units) Table 109. Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2027-2032) & (K Units) Table 110. Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2026) & (K Units) Table 113. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2027-2032) & (K Units) Table 114. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Type (2021-2026) Table 115. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Type (2027-2032) Table 116. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Type (2021-2026) Table 119. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Type (2027-2032) Table 120. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Type (2021-2026) & (US$/Unit) Table 121. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Type (2027-2032) & (US$/Unit) Table 122. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2026) & (K Units) Table 123. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2027-2032) & (K Units) Table 124. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Application (2021-2026) Table 125. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Application (2027-2032) Table 126. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Application (2021-2026) Table 129. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Application (2027-2032) Table 130. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Application (2021-2026) & (US$/Unit) Table 131. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Distributors List Table 135. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Customers List Table 136. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Trends Table 137. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Drivers Table 138. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Image Figure 5. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size (2021-2032) & (US$ Million) Figure 7. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (2021-2032) & (K Units) Figure 8. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Average Price (US$/Unit) & (2021-2032) Figure 9. Sequencing Method Product Image Figure 10. Fluorescence PCR Method Product Image Figure 11. Other Product Image Figure 12. Clinical Product Image Figure 13. Scientific Research Product Image Figure 14. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region in 2025 Figure 20. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region in 2025 Figure 21. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country in 2025 Figure 22. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2021-2032) Figure 23. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Country (2021-2032) Figure 24. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country in 2025 Figure 28. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2021-2032) Figure 29. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Country (2021-2032) Figure 30. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country in 2025 Figure 41. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Country (2021-2032) Figure 43. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country in 2025 Figure 52. South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2021-2032) Figure 53. South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Country (2021-2032) Figure 54. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country in 2025 Figure 58. Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Country (2021-2032) Figure 60. Egypt Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Type (2021-2032) Figure 66. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Type (2021-2032) Figure 67. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price (US$/Unit) by Type (2021-2032) Figure 68. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Application (2021-2032) Figure 69. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Application (2021-2032) Figure 70. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price (US$/Unit) by Application (2021-2032) Figure 71. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Value Chain Figure 72. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Opportunities and Challenges

Scope & coverage.

Types
  • Sequencing Method
  • Fluorescence PCR Method
  • Other
Applications
  • Clinical
  • Scientific Research
Companies covered
  • Yuanma Gene
  • Shihe Medical
  • Xiamen Feishuo Biotechnology
  • Burning Rock
  • Qiuzhen Medical
  • Novogene
  • Jinqirui Biotechnology
  • BGI
  • Hangzhou Lianchuan Gene
  • TRUPCR
  • HLB PanaGene
  • AmoyDx

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size (2021-2032)
  4. 2.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (2021-2032)
  5. 2.2.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Average Price (2021-2032)
  6. 2.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Sequencing Method
  9. 2.3.3 Fluorescence PCR Method
  10. 2.3.4 Other
  11. 2.4 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Clinical
  14. 2.4.3 Scientific Research
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, Product Type & Application
  8. 3.8 Global Manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, Established Date
  9. 3.9 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Yuanma Gene
  2. 4.1.1 Yuanma Gene Company Information
  3. 4.1.2 Yuanma Gene Business Overview
  4. 4.1.3 Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  6. 4.1.5 Yuanma Gene Recent Developments
  7. 4.2 Shihe Medical
  8. 4.2.1 Shihe Medical Company Information
  9. 4.2.2 Shihe Medical Business Overview
  10. 4.2.3 Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  12. 4.2.5 Shihe Medical Recent Developments
  13. 4.3 Xiamen Feishuo Biotechnology
  14. 4.3.1 Xiamen Feishuo Biotechnology Company Information
  15. 4.3.2 Xiamen Feishuo Biotechnology Business Overview
  16. 4.3.3 Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  18. 4.3.5 Xiamen Feishuo Biotechnology Recent Developments
  19. 4.4 Burning Rock
  20. 4.4.1 Burning Rock Company Information
  21. 4.4.2 Burning Rock Business Overview
  22. 4.4.3 Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  24. 4.4.5 Burning Rock Recent Developments
  25. 4.5 Qiuzhen Medical
  26. 4.5.1 Qiuzhen Medical Company Information
  27. 4.5.2 Qiuzhen Medical Business Overview
  28. 4.5.3 Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  30. 4.5.5 Qiuzhen Medical Recent Developments
  31. 4.6 Novogene
  32. 4.6.1 Novogene Company Information
  33. 4.6.2 Novogene Business Overview
  34. 4.6.3 Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  36. 4.6.5 Novogene Recent Developments
  37. 4.7 Jinqirui Biotechnology
  38. 4.7.1 Jinqirui Biotechnology Company Information
  39. 4.7.2 Jinqirui Biotechnology Business Overview
  40. 4.7.3 Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  42. 4.7.5 Jinqirui Biotechnology Recent Developments
  43. 4.8 BGI
  44. 4.8.1 BGI Company Information
  45. 4.8.2 BGI Business Overview
  46. 4.8.3 BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  48. 4.8.5 BGI Recent Developments
  49. 4.9 Hangzhou Lianchuan Gene
  50. 4.9.1 Hangzhou Lianchuan Gene Company Information
  51. 4.9.2 Hangzhou Lianchuan Gene Business Overview
  52. 4.9.3 Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  54. 4.9.5 Hangzhou Lianchuan Gene Recent Developments
  55. 4.10 TRUPCR
  56. 4.10.1 TRUPCR Company Information
  57. 4.10.2 TRUPCR Business Overview
  58. 4.10.3 TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  60. 4.10.5 TRUPCR Recent Developments
  61. 4.11 HLB PanaGene
  62. 4.11.1 HLB PanaGene Company Information
  63. 4.11.2 HLB PanaGene Business Overview
  64. 4.11.3 HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  66. 4.11.5 HLB PanaGene Recent Developments
  67. 4.12 AmoyDx
  68. 4.12.1 AmoyDx Company Information
  69. 4.12.2 AmoyDx Business Overview
  70. 4.12.3 AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
  72. 4.12.5 AmoyDx Recent Developments
5 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Scenario by Region
  1. 5.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region: 2021-2032
  3. 5.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region: 2021-2026
  4. 5.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region: 2027-2032
  5. 5.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region: 2021-2032
  6. 5.3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region: 2021-2026
  7. 5.3.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region: 2027-2032
  8. 5.4 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Facts & Figures by Country
  9. 5.4.1 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2032)
  11. 5.4.3 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Facts & Figures by Country
  16. 5.5.1 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2032)
  18. 5.5.3 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Facts & Figures by Country
  41. 5.7.1 South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2032)
  43. 5.7.3 South America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2032)
  2. 6.1.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Type (2021-2032)
  4. 6.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021-2032)
  5. 6.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2032)
  2. 7.1.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Application (2021-2032)
  4. 7.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021-2032)
  5. 7.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Value Chain Analysis
  2. 8.1.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Production Mode & Process
  5. 8.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Distributors
  8. 8.2.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Customers
9 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Analyzing Market Dynamics
  1. 9.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Trends
  2. 9.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Drivers
  3. 9.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Opportunities and Challenges
  4. 9.4 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst